Author: Marjorie C. Weiss
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Factors Influencing the Prescribing Decisions of General Practitioners
Factors Influencing the Prescribing Decisions of General Practitioners /Margorie Cecilia Weiss
Author: Margorie Cecilia Weiss
Publisher:
ISBN:
Category : Family medicine
Languages : en
Pages : 458
Book Description
Publisher:
ISBN:
Category : Family medicine
Languages : en
Pages : 458
Book Description
Factors that influence physicians' prescribing decisions
Pharmaceutical Prices in the 21st Century
Author: Zaheer-Ud-Din Babar
Publisher: Springer
ISBN: 3319121693
Category : Business & Economics
Languages : en
Pages : 410
Book Description
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Publisher: Springer
ISBN: 3319121693
Category : Business & Economics
Languages : en
Pages : 410
Book Description
This book provides an overview of the global pharmaceutical pricing policies. Medicines use is increasing globally with the increase in resistant microbes, emergence of new treatments, and because of awareness among consumers. This has resulted in increased drug expenditures globally. As the pharmaceutical market is expanding, a variety of pharmaceutical pricing strategies and policies have been employed by drug companies, state organizations and pharmaceutical pricing authorities.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
An Evaluation of the Promotional Factors Influencing General Practitioners' Prescribing Behaviour, Primarily the Pharmaceutical Representative
Author: Paresh Kumar V. Patel
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category : Pharmaceutical industry
Languages : en
Pages :
Book Description
General Practitioners Confidence in Diagnosis and Factors Influencing Prescribing
Ethical Criteria for Medicinal Drug Promotion
Author: World Health Organization
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 32
Book Description
"Resolution WHA41.17 adopted by the Forty-first World Health Assembly, 13 May 1988" -- p.1.
Publisher:
ISBN:
Category : Business & Economics
Languages : en
Pages : 32
Book Description
"Resolution WHA41.17 adopted by the Forty-first World Health Assembly, 13 May 1988" -- p.1.
Factors Influencing General Practitioners in Their Choice of Prescription Drugs
Author: Mark I. Friedman
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 190
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 190
Book Description
Practical Implementation of an Antibiotic Stewardship Program
Author: Tamar F. Barlam
Publisher: Cambridge University Press
ISBN: 1107166179
Category : Medical
Languages : en
Pages : 343
Book Description
This practical reference guide from experts in the field details why and how to establish successful antibiotic stewardship programs.
Publisher: Cambridge University Press
ISBN: 1107166179
Category : Medical
Languages : en
Pages : 343
Book Description
This practical reference guide from experts in the field details why and how to establish successful antibiotic stewardship programs.